Index of /wp-content/uploads/2023/05

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[IMG]Screenshot-2023-05-14-at-10.47.49-AM.png2025-05-06 14:18 10M 
[IMG]GridArt_20230505_210318155.jpg2025-05-06 14:18 8.6M 
[SND]SUN0320230526146870-Q4FY23-Conf.-Call-Audio.mp32025-05-06 14:18 7.5M 
[ ]IntimationSigned-23.pdf2025-05-06 14:18 7.3M 
[ ]OutcomeSigned.pdf2025-05-06 14:18 5.7M 
[IMG]16840342145074941235422228181790.jpg2025-05-06 14:18 4.8M 
[IMG]tempImage8vwTHw.jpg2025-05-06 14:18 3.2M 
[IMG]IMG-20230511-WA0000.jpeg2025-05-06 14:18 3.2M 
[IMG]IMG_20230522_222103.jpg2025-05-06 14:18 3.1M 
[ ]FE_Ahmedabad-Eng_Gujarati.pdf2025-05-06 14:18 3.1M 
[IMG]IMG_20230528_201837.jpg2025-05-06 14:18 2.7M 
[IMG]20230503_191323.jpg2025-05-06 14:18 2.6M 
[ ]Q4FY23-Financial-Result-1.pdf2025-05-06 14:18 2.5M 
[IMG]20230511_221855.jpg2025-05-06 14:18 1.9M 
[ ]2SEIntimationSigned.pdf2025-05-06 14:18 1.4M 
[IMG]IMG_20230531_203952.jpg2025-05-06 14:18 1.2M 
[ ]IntimationFinalSigned-1.pdf2025-05-06 14:18 1.2M 
[ ]Fillable_Link_ISR-1_-Request-form-for-Registering-PanBankKYC.pdf2025-05-06 14:18 1.2M 
[ ]IntimationSigned-22.pdf2025-05-06 14:18 1.0M 
[ ]3OutcomeDirectorsSigned.pdf2025-05-06 14:18 964K 
[ ]IntimationSigned-20.pdf2025-05-06 14:18 908K 
[ ]IntimationSigned-21.pdf2025-05-06 14:18 878K 
[ ]1AdditionalLetterSigned.pdf2025-05-06 14:18 876K 
[ ]Circular-Common-Norms.pdf2025-05-06 14:18 755K 
[IMG]noculi-b6-oral-solution_contains_SORBITOL.png2025-05-06 14:18 732K 
[ ]Press-Release-Sun-Pharma-Philogen-Final.pdf2025-05-06 14:18 422K 
[ ]Fillable-Link-ISR-2_-Bank_verification-for-Sign.pdf2025-05-06 14:18 414K 
[IMG]WhatsApp-Image-2023-05-12-at-1.08.02-PM.jpeg2025-05-06 14:18 344K 
[ ]Fillable-Link_SH-14-_Cancellation-or-variation-of-nomination_.pdf2025-05-06 14:18 263K 
[ ]Fillable-Link_SH-13-_Reg-of-Nomination.pdf2025-05-06 14:18 253K 
[ ]IntimationSE20220602_for_Analyst_and_Investor_meeting_Signed_2_June_22.pdf2025-05-06 14:18 216K 
[ ]Fillable-Link_ISR-3-_Opt-Out_.pdf2025-05-06 14:18 199K 
[ ]rolsical..pdf2025-05-06 14:18 187K 
[ ]Press-Release-Sun-Pharma-Q4FY23-Financial-Result-1.pdf2025-05-06 14:18 185K 
[ ]IntimationSE20230526_Disclosure_Earnings_Call_Audio_Signed.pdf2025-05-06 14:18 182K 
[ ]BMW-Disposal-Summary-April-23-Sun-Pharma.pdf2025-05-06 14:18 157K 
[IMG]IMG-20230516-WA0000.jpg2025-05-06 14:18 139K 
[ ]Press-Release-Sun-Pharma-Q4-FY23-financial-result-on-May-26-2023-2.pdf2025-05-06 14:18 131K 
[ ]Press-Release-Sun-Pharma-Q4-FY23-financial-result-on-May-26-2023-1.pdf2025-05-06 14:18 131K 
[ ]Press-Release-Sun-Pharma-Q2-FY23-financial-result-on-November-01-2022.pdf2025-05-06 14:18 130K 
[ ]IntimationSE20220811_for_Analyst_and_Investor_meetingSigned_11_Aug_22.pdf2025-05-06 14:18 103K 
[ ]4IntinationSE20230527MeetingSchedule.pdf2025-05-06 14:18 102K 
[ ]IntimationSE20230530AnalystMeetIntimationSinged.pdf2025-05-06 14:18 101K 
[ ]Copy-of-RcvExceptionSaltLake528916447825745625RD20230410125932.xlsx2025-05-06 14:18 92K 
[ ]IntimationSE20220524_for_Analyst_and_Investor_meeting_24_May_22.pdf2025-05-06 14:18 84K 
[ ]SPIL-Familiarization-Program-2022-23_final.pdf2025-05-06 14:18 77K 
[ ]Press-Release-Sun-Pharma-Announces-China-NMPA-Approval-for-ILUMETRI-Tildrakizumab-Injection-For-Treatment-of-Adults-with-Moderate-To-Severe-Plaque-Psoriasis.pdf2025-05-06 14:18 50K 
Apache/2.4.52 (Ubuntu) Server at sunpharma.com Port 80